A smallish item here, but another Merck alum has landed on a public company board -- this time at a pet med company called Aratana. Here's the [California] Sacramento Bee, on it:
. . . .Jay Lichter, PhD, Aratana's Chairman of the Board, stated, "Ms. Yarno's impressive career at Merck and her deep board experience make her an excellent addition. We expect to benefit greatly from her expertise". . . .
Ms. Yarno held positions of increasing responsibility in multiple business groups during her career at Merck & Co, Inc. Most recently she served as Chief Marketing Officer, where she led the global organization responsible for supporting product commercialization across multiple therapeutic areas. At one point during her career, Ms. Yarno served as Merck's Senior Vice President of Human Resources. Ms. Yarno received an MBA from the Fox School of Business at Temple University and a B.S. in business administration from Portland State University. She also serves on the Board of Directors for St. Jude Medical, Medivation, ADial Pharmaceuticals, and PluroGen Therapeutics. . . .
Nothing written, appearing, or linked to, on this site is intended to be individual legal, or investment, advice. Consult a financial or legal adviser before making any trade, or any other decision, based anything you read, or see, on this website. This website treats all U.S. viewers' vistor-paths -- and visits -- as public data. If you are from Europe, understand that this site can see -- but will not disclose to the public -- your visitor-path, in compliance with applicable E.U. directives. All material on this website is derived from public documents, and/or edited, modified, and derived from public domain sources, or in some cases, originally-created by the author(s) of this site. Any use of any proprietary image, document or other data is genuinely-intended by the author(s) to fall under the common-law "fair use" doctrine, as criticism of, and commentary on, matters of substantial public concern -- among them, the for-profit health care system in the Americas. If any person wishes to dispute this assertion of "fair use", please leave a comment in any of the comment-boxes, specifically-identifying the challenged material, and the basis for the challenge, on this site. The Site Administrator(s) will promptly consider the claim. In the same comment-box, the Site Administrator(s) will indicate the site's position on any such claim. This site is not-for-profit. Share, and share-a-like, licenses granted in, and to, all content. Copy-left 2008 though 2016.